Equities News

Followers (7)

Following

The Life Sciences Report $the-life-science-report

The Life Sciences Report: Featuring investment ideas in biotechnology, pharmaceuticals, medical devices, tools and diagnostics in interviews with industry-sector experts–analysts, money managers and newsletter writers–backed by the latest research summaries, news and company profiles. It's a combination of information and insight investors can't get anywhere else.

Articles (71)

Article's title	Publish date
Biopharma's Migraine Phase 3 Trial Results 'Robust,' 'Impressive'	Jan 3, 2020
Cancer Vaccine Developer Expands Its Collaboration with Merck	Sep 19, 2018
Coverage Initiated on 'Emerging Antibiotics Growth Story with Multiple Levers for Upside'	Sep 19, 2018
Medical Use of Nitric Oxide Expands as Costs Come Down	Sep 19, 2018
U.S. Biotech Partner Obtains Marketing Authorization for ADHD Treatment in Taiwan	Sep 18, 2018
Why Tiny ITUS's CAR-T Therapy Could Be a Big Deal in Cancer Treatment	Sep 14, 2018
Canadian Biopharma to Outlicense Pain Drug to South Korean Firm	Sep 12, 2018
Biopharma's Positive FDA Meeting Outlines Path Forward for Trial	Sep 11, 2018
Final Approval of Biopharma's Lead Candidate Both Likely and Imminent	Sep 5, 2018
Coverage Initiated on Firm with Paradigm-Shifting Colonoscopy Device	Sep 5, 2018

Page 1 of 8

There are no recent news available for The Life Sciences Report.

The Life Sciences Report $the-life-science-report

Show More

Today's Must Reads

Lyft Posts First Adjusted Quarterly Profit But Warns of Driver Shortage

California's Largest Wildfire Grows Amid Severe Weather Conditions

Amgen Beats Q2 Estimates But Guides Lower for Full Year

CDC Issues New Moratorium on Evictions Until October 3

Amazon Interfered With Union Vote in Alabama: NLRB Officer

President Biden, Other Democrats Urge Governor Cuomo To Resign

US Automakers and UAW Reinstate Face Mask Requirements at All Plants

DeSantis Downplays Risks as Florida Breaks Records for COVID-19 Hospitalizations

Spirit Airlines Cancels Nearly Half Its Tuesday Schedule, Third Straight Day of High Cancellations

US Factory Orders Rose 1.5% in June, Ahead of Forecasts

Johnson & Johnson Says Indian Government Discussions Continue on COVID-19 Vaccine

Combination of AstraZeneca's Vaccine and mRNA Vaccines Found To Be 88% Effective Against COVID-19

RELEASING NOV-25: Greenwich Economic Forum (Full Event Coverage)